Experimental cancer portfolio
Birmingham ECMC funding facilitates the development and delivery of innovative early phase trials, supporting key posts within the Cancer Research UK Clinical Trials Unit.
View the pie chart in a table version.
Case Study: Precision Medicine
Birmingham Director Professor Gary Middleton leads the National Lung Matrix Trial, a highly innovative umbrella trial evaluating drugs targeting patients’ genetic mutations. National Lung Matrix is the largest precision medicine trial in non-small cell lung cancer globally. It is delivered nationally across the ECMC network, with seventeen ECMCs among the twenty recruiting sites.